Funded Tech Companies
Breye Therapeutics
Wondering who invested in Breye Therapeutics? EIFO, Pappas Capital and Mission BioCapital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Breye Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Denmark, SC Undisclosed
USA
Denmark, SC Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Breye Therapeutics is a clinical stage clinical biopharmaceutical company developing novel oral therapies for retinal vascular diseases within ophthalmology. Breye has two novel and relevant small molecule oral therapies to address large unmet medical needs in both diabetic retinopathy (DR) and age-related macular degeneration (AMD)
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/29/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ulrik Mouritzen
Company Investors
- EIFO
- Pappas Capital
- Mission BioCapital (Robert Blazej)
- The Ljungstrom Family Office
- Modi Ventures
- Sound Bioventures (Johan Kördel)
- Innovestor
- Novo Holdings (Jørgen Petersen)
- BioInnovation Institute
- Innovation Fund Denmark
- Vaekstfonden
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs